GH-31
N/A
Report date: 2026/02/14 20:00:22
NME
Base Information
Drug NameGH-31
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSuzhou Genhouse Bio Co Ltd
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesGilead Sciences IncSuzhou Genhouse Bio Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A